Trial · NCT03100058
Outcomes20
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percent Change From Baseline in Body Weight at 24 Weeks | Baseline, Week 24 (Epoch 3) | Full Analysis Set | Percent change | MEAN |
| SECONDARY | Number of Subjects With Response Rate According to Percent Decrease in Body Weight for Overall Study | Baseline, Week 24 | Full Analysis Set | Percentage | NUMBER |
| SECONDARY | Number of Subjects With Response Rate According to Percent Decrease in Body Weight for Subgroups | Baseline, Week 24 | Full Analysis Set | Percentage | NUMBER |
| SECONDARY | Percentage Change From Baseline on Waist Circumference | Baseline, Week 24 (Epoch 3), Week 24 to Week 48 (Epoch 4) | Full Analysis Set | Percentage Change | MEAN |
| SECONDARY | Change From Baseline in Fasting Plasma Glucose (FPG) in Type 2 Diabetes Mellitus Patients (T2DM) | Baseline, Week 24 (Epoch 3), Week 24 to Week 48 (Epoch 4) | Full Analysis Set | mmol/L | MEAN |
| SECONDARY | Change From Baseline in Glycated Hemoglobin A1c (HbA1c) in Type 2 Diabetes Mellitus Patients (T2DM) | Baseline, Week 24 (Epoch 3), Week 24 to week 48 (Epoch 4) | Full Analysis Set | mmol/L | MEAN |
| SECONDARY | Change From Baseline in Mean Sitting Systolic Blood Pressure (msSBP) and Mean Sitting Diastolic Blood Pressure (msDBP) | Baseline, Week 24 (Epoch 3) Week 24 to Week 48 (Epoch 4) | Full Analysis Set | mmHg | MEAN |
| SECONDARY | Change From Baseline in 24-hour Urinary Glucose Excretion | Baseline, week 24 (Epoch 3), Week 24 to Week 48 (Epoch 4) | Full Analysis Set | mmol/24hr | MEAN |
| SECONDARY | Percentage Change in Weight in the Overall Population and by Subgroups (Epoch 4) | Between Week 24 and Week 48 (Epoch 4) | Full Analysis Set | Percentage | MEAN |
| SECONDARY | Change From Baseline to Week 24 (Epoch 3) in the 24-hour Urinary Calcium Excretion | Baseline, Week 24 | Full Analysis Set | mmol/24hr | MEAN |
| SECONDARY | Change From Baseline Week 24 to Week 48 (Epoch 4) in the 24-hour Urinary Calcium Excretion | Baseline, Week 24, Week 48 | Full Analysis Set | mmol/24hr | MEAN |
| SECONDARY | Change From Baseline to Week 24 (Epoch 3) in the 24-hour Urinary Phosphorus Excretion | Week 24, Week 48 | Full Analysis Set | mmol/24hr | MEAN |
| SECONDARY | Change From Baseline Week 24 to Week 48 (Epoch 4) in the 24-hour Urinary Phosphorus Excretion | Week 24, Week 48 | Full Analysis Set | mmol/24hr | MEAN |
| SECONDARY | Change From Baseline in Fasting Lipid Profile (Lipoproteins) | Baseline, Week 24, Week 24 to Week 48 (Epoch 4) | Full Analysis Set | g/L | MEAN |
| SECONDARY | Change From Baseline in High Sensitive C-reactive Protein (hsCRP) | Baseline to Week 24, Week 24 to Week 48 (Epoch 4) | Full Analysis Set | mg/L | GEOMETRIC_MEAN |
| SECONDARY | Change From Baseline in Fasting Lipid Profile (Triglycerides/Cholesterol) | Baseline to Week 24, Week 24 to Week 48 (Epoch 4) | Full Analysis Set | mmol/L | MEAN |
| SECONDARY | Pharmacokinetics of LIK066: Observe Maximum Plasma Concentration (Cmax) | Summary at Week 24 from qd or bid regimens | Full Analysis Set | ng/mL | MEAN |
| SECONDARY | Pharmacokinetics of LIK066: Time to Reach the Maximum Concentration (Tmax) | Summary at Week 24 for qd or bid regimens | Full Analysis Set | hour | MEDIAN |
| SECONDARY | Pharmacokinetics of LIK066: Area Under the Plasma Concentration-time Curve From Time Zero Time 't' (AUC0-t) | Summary at Week 24 from qd or bid regimens (0-6h) | Full Analysis Population | hr*ng/mL | MEAN |
| SECONDARY | Pharmacokinetics of LIK066: Last Non-zero Concentration Area Under the Curve (AUClast) | Summary at Week 24 from qd or bid regimens | Full Analysis Set | hr*ng/mL | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03100058/outcomes